Hurco Companies HURC Stalls at 1650 Consolidation Phase 20260514 Microsoft Corporation MSFT Delivers Q1 2026 Beat EPS 427 vs 414 Expected Why McKesson Corporation MCK Just Surged 200 Key Levels Ahead 20260518 Arc Raiders Map Expansion Embark Studios Faces Backlash Over Update Strategy Marc Jacobs Leaves LVMH Portfolio After Three Decades Remains Creative Director Crypto Companies Shift Focus from Volatility to Discipline Earnings Indicate Singapore Stocks Rally 15 as STI Closes Above 5070 Amid Mixed Regional Markets Wintrust WTFCN Q1 2026 Results Exceed Forecasts Key Drivers Inside Chip Leaders PostEarnings Decline May Signal Technical Reversal Retail Investors Gain Unprecedented Access to Potential SpaceX IPO Through Major Brokerages RBI Surprises with 25 bps Rate Cut to 625 Nomura Warns Policy Framework Diluted Wall Street Analysts Set Sights on Paychex What Do Their Price Targets Indicate Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Blocker Effects Pokmon Card Market Surges Amid Nostalgia Speculation and HighProfile Collectors AZN Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operational Results VIR Q1 2026 Earnings Significant EPS Miss as Biotech Continues Investment Phase NVNO Q3 2025 Earnings EPS Beat Signals Progress in Cost Management and Clinical Milestones VICR Q1 2026 Earnings EPS Surges Past Estimates Despite Subdued Stock Reaction AbbVie ABBV Q1 2026 Earnings Slight EPS Beat Amid Steady Performance Meta Settles Landmark Social Media Addiction Lawsuit with US School District CarPartscom PRTS Q1 2026 Earnings EPS Beat Despite Challenging Environment European Telecoms CEO Flags Growing Risk of US Dominance in Satellite and AI Sectors Target Corporation TGT Rebounds Can It Breach Resistance Jeff Bezos Defends Billionaires Champions AI Discusses Tax Reform and Praises Trump in CNBC Interview Archimedes 3 ARCIW Holds 049 Direction Awaited 20260520 Royal Observatory Warns Against AI Dependency Raises Questions on Human Value in TechDriven Economy First Bank FRBA Stages a Modest Rally Testing Key Resistance Levels Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Pipeline Progress in Focus